Title | Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Napoli S, Cascione L, Rinaldi A, Spriano F, Guidetti F, Zhang F, Cacciapuoti MTeresa, Mensah AAdjeiwaa, Sartori G, Munz N, Forcato M, Bicciato S, Chiappella A, Ghione P, Elemento O, Cerchietti L, Inghirami G, Bertoni F |
Journal | Haematologica |
Volume | 107 |
Issue | 5 |
Pagination | 1131-1143 |
Date Published | 2022 May 01 |
ISSN | 1592-8721 |
Keywords | Enhancer Elements, Genetic, Humans, Lymphoma, Large B-Cell, Diffuse, RNA, RNA, Untranslated, Transcription, Genetic |
Abstract | Enhancers are regulatory regions of DNA, which play a key role in cell-type specific differentiation and development. Most active enhancers are transcribed into enhancer RNA (eRNA) that can regulate transcription of target genes by means of in cis as well as in trans action. eRNA stabilize contacts between distal genomic regions and mediate the interaction of DNA with master transcription factors. Here, we characterized an enhancer eRNA, GECPAR (germinal center proliferative adapter RNA), which is specifically transcribed in normal and neoplastic germinal center B cells from the super-enhancer of POU2AF1, a key regulatory gene of the germinal center reaction. Using diffuse large B-cell lymphoma cell line models, we demonstrated the tumor suppressor activity of GECPAR, which is mediated via its transcriptional regulation of proliferation and differentiation genes, particularly MYC and the Wnt pathway. |
DOI | 10.3324/haematol.2020.267096 |
Alternate Journal | Haematologica |
PubMed ID | 34162177 |
PubMed Central ID | PMC9052922 |
Grant List | P01 CA229100 / CA / NCI NIH HHS / United States |